HemoGenyx Pharmaceuticals Plc's market cap is currently £62.46M. The company's EPS TTM is p-1.415; its P/E ratio is ―; HemoGenyx Pharmaceuticals Plc is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in GBP
HemoGenyx Pharmaceuticals Plc Earnings and Revenue History
